Figure S1 from <i>De Novo</i> Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression

Naveen Kumar Tangudu,Raquel Buj, Hui Wang,Jiefei Wang, Aidan R. Cole,Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang,Adam Chatoff, Claudia V. Crispim,Peter Sajjakulnukit,Maureen A. Lyons,Kristine Cooper,Nadine Hempel,Costas A. Lyssiotis,Uma R. Chandran,Nathaniel W. Snyder,Katherine M. Aird

crossref（2024）

引用 0|浏览4

暂无评分

摘要

Knockdown of p16 or Cdkn2a in human and mouse melanoma cell lines, respectively, and DepMap dependency score data based on CDKN2A expression. Related to Figure 1.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Figure S1 from &lt;i&gt;De Novo&lt;/i&gt; Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression

Figure S1 from <i>De Novo</i> Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression